S&P 500 Futures
(-0.07%) 5 304.50 points
Dow J Futures
(-0.02%) 40 134 points
Nasdaq Futures
(-0.11%) 18 484 points
Oil
(0.77%) $81.98
Gas
(-1.75%) $1.688
Gold
(0.28%) $2 218.80
Silver
(-0.64%) $24.59
Platinum
(-0.01%) $909.60
USD/EUR
(0.46%) $0.928
USD/NOK
(0.69%) $10.84
USD/GBP
(0.28%) $0.793
USD/RUB
(-0.15%) $92.31

Realtime updates for InDex Pharmaceuticals [INDEX.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 05:54

-0.34% SEK 0.297

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 05:54):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis...

Stats
Today's Volume 891 670
Average Volume 1.51M
Market Cap 158.21M
EPS SEK0 ( 2024-02-20 )
Next earnings date ( SEK0 ) 2024-05-06
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -3.30
ATR14 SEK0.00300 (1.01%)

Volume Correlation

Long: -0.12 (neutral)
Short: -0.37 (neutral)
Signal:(51.716) Neutral

InDex Pharmaceuticals Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

InDex Pharmaceuticals Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.28
( neutral )

InDex Pharmaceuticals Financials

Annual 2023
Revenue: SEK97.51M
Gross Profit: SEK-95.71M (-98.16 %)
EPS: SEK-0.180
Q4 2023
Revenue: SEK0
Gross Profit: SEK-304 000 (0.00 %)
EPS: SEK-0.200
Q3 2023
Revenue: SEK0
Gross Profit: SEK-1.56M (0.00 %)
EPS: SEK-0.0712
Q2 2023
Revenue: SEK97.51M
Gross Profit: SEK96.42M (98.88 %)
EPS: SEK0.170

Financial Reports:

No articles found.

InDex Pharmaceuticals

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences in preclinical stage for the treatment of various immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators